Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic.
Parisi A, Giampieri R, Villani S, Magnarini A, Gelsomino F, Traisci D, Barbin F, Salvatore L, Zichi C, Di Pietro FR, Zoratto F, Lanese A, Petrillo A, Zurlo IV, Spallanzani A, D'Ostilio N, Ghidini M, Bensi M, Schietroma F, Rognone C, Panepinto O, Paparo J, Gamba T, Bisonni R, Di Lorenzo S, Daniele B, Mentrasti G, Berardi R. Parisi A, et al. Among authors: di pietro fr. Oncologist. 2024 Nov 26:oyae310. doi: 10.1093/oncolo/oyae310. Online ahead of print. Oncologist. 2024. PMID: 39591103 Free article.
Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study.
Verkhovskaia S, Falcone R, Di Pietro FR, Carbone ML, Samela T, Perez M, Poti G, Morelli MF, Zappalà AR, Di Rocco ZC, Morese R, Piesco G, Chesi P, Marchetti P, Abeni D, Failla CM, De Galitiis F. Verkhovskaia S, et al. Among authors: di pietro fr. Cancers (Basel). 2024 Oct 4;16(19):3397. doi: 10.3390/cancers16193397. Cancers (Basel). 2024. PMID: 39410017 Free PMC article.
Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience.
Di Pietro FR, Marinelli D, Verkhovskaia S, Poti G, Falcone R, Carbone ML, Morelli MF, Zappalà AR, Di Rocco ZC, Morese R, Piesco G, Chesi P, Marchetti P, Failla CM, De Galitiis F. Di Pietro FR, et al. BMC Cancer. 2024 Oct 1;24(1):1220. doi: 10.1186/s12885-024-12961-9. BMC Cancer. 2024. PMID: 39354418 Free PMC article.
Compressed SENSitivity Encoding (SENSE): Qualitative and Quantitative Analysis.
Picchi E, Minosse S, Pucci N, Di Pietro F, Serio ML, Ferrazzoli V, Da Ros V, Giocondo R, Garaci F, Di Giuliano F. Picchi E, et al. Among authors: di pietro f. Diagnostics (Basel). 2024 Aug 5;14(15):1693. doi: 10.3390/diagnostics14151693. Diagnostics (Basel). 2024. PMID: 39125569 Free PMC article.
Infectious Keratitis: Characterization of Microbial Diversity through Species Richness and Shannon Diversity Index.
Schiano-Lomoriello D, Abicca I, Contento L, Gabrielli F, Alfonsi C, Di Pietro F, Papa FT, Ballesteros-Sánchez A, Sánchez-González JM, Rocha-De-Lossada C, Mazzotta C, Giannaccare G, Bonzano C, Borroni D. Schiano-Lomoriello D, et al. Among authors: di pietro f. Biomolecules. 2024 Mar 24;14(4):389. doi: 10.3390/biom14040389. Biomolecules. 2024. PMID: 38672407 Free PMC article.
Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center.
Falcone R, Verkhovskaia S, Di Pietro FR, Poti G, Samela T, Carbone ML, Morelli MF, Zappalà AR, di Rocco ZC, Morese R, Piesco G, Marchetti P, Failla CM, De Galitiis F. Falcone R, et al. Among authors: di pietro fr. Curr Oncol. 2024 Jan 22;31(1):588-597. doi: 10.3390/curroncol31010042. Curr Oncol. 2024. PMID: 38275835 Free PMC article.
Tactile acuity improves during acute experimental pain of the limb.
Paredes Sanchez J, Titmus M, Lawson-Smith H, Di Pietro F. Paredes Sanchez J, et al. Among authors: di pietro f. Pain Rep. 2023 Aug 3;8(5):e1091. doi: 10.1097/PR9.0000000000001091. eCollection 2023 Sep. Pain Rep. 2023. PMID: 38225958 Free PMC article.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
Celsa C, Cabibbo G, Fulgenzi CAM, Scheiner B, D'Alessio A, Manfredi GF, Nishida N, Ang C, Marron TU, Saeed A, Wietharn B, Pinter M, Cheon J, Huang YH, Lee PC, Phen S, Gampa A, Pillai A, Vivaldi C, Salani F, Masi G, Roehlen N, Thimme R, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Galle PR, Kudo M, Rimassa L, Singal AG, El Tomb P, Ulahannan S, Parisi A, Chon HJ, Hsu WF, Stefanini B, Verzoni E, Giusti R, Veccia A, Catino A, Aprile G, Guglielmini PF, Di Napoli M, Ermacora P, Antonuzzo L, Rossi E, Verderame F, Zustovich F, Ficorella C, Di Pietro FR, Battelli N, Negrini G, Grossi F, Bordonaro R, Pipitone S, Banzi M, Ricciardi S, Laera L, Russo A, De Giorgi U, Cavanna L, Sorarù M, Montesarchio V, Bordi P, Brunetti L, Pinto C, Bersanelli M, Cammà C, Cortellini A, Pinato DJ. Celsa C, et al. Among authors: di pietro fr. J Hepatol. 2024 Mar;80(3):431-442. doi: 10.1016/j.jhep.2023.10.040. Epub 2023 Nov 15. J Hepatol. 2024. PMID: 37972660 Free article.
111 results